Full-Time

Hyperion Administrator

Confirmed live in the last 24 hours

ZOLL Medical Corporation

ZOLL Medical Corporation

1,001-5,000 employees

Data & Analytics
Healthcare

Senior

Lowell, MA, USA

Category
Financial Planning and Analysis (FP&A)
Finance & Banking

You match the following ZOLL Medical Corporation's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor’s degree in Finance, Business, or a related field
  • Minimum of 5 years of relevant experience
  • Excellent problem-solving and analytical skills
  • Strong communication skills
  • Attention to detail
  • Strong work ethic
  • Experience with in Hyperion maintenance and report writing
Responsibilities
  • Administer and maintain Hyperion applications including HFM and Hyperion Planning
  • Design, develop, and maintain Hyperion reports to meet business requirements by utilizing Financial Reporting Studio
  • Maintain and update metadata members and hierarchy within Hyperion applications using Hyperion Financial Management
  • Manage user access, roles, and permissions within Hyperion applications
  • Provide support and training to end-users, addressing issues and queries related to Hyperion systems
  • Perform regular system backups, updates, and patching
  • Maintain system documentation as required for audit
  • Special Projects as required
ZOLL Medical Corporation

ZOLL Medical Corporation

View

Company Size

1,001-5,000

Company Stage

Acquired

Total Funding

N/A

Headquarters

null

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased telehealth adoption drives demand for ZOLL's advanced medical devices.
  • Personalized medicine trends allow ZOLL to create tailored solutions for patient needs.
  • AI-driven diagnostic tools offer ZOLL opportunities to enhance device capabilities.

What critics are saying

  • Ransomware attack leads to potential legal liabilities and financial costs for ZOLL.
  • Increased competition in defibrillators could impact ZOLL's market share.
  • Rapid tech advancements may strain ZOLL's resources and increase R&D costs.

What makes ZOLL Medical Corporation unique

  • ZOLL's AR Boost tool ranks #1 in 2024 Insurance Discovery Solutions.
  • ZOLL AED 3 defibrillator is EU MDR certified, ensuring high safety and quality standards.
  • ZOLL received an Innovative Technology contract for Therox SSO2 Therapy from Vizient.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Casual Work Environment

Company News

ZOLL Data
Aug 6th, 2024
Black Book Research Ranks ZOLL(R) AR Boost(R) as the #1 2024 Insurance Discovery Solution

The ZOLL AR Boost(R) Insurance Discovery tool secured the #1 spot in the 2024 Insurance Discovery Solutions category.

Law360
Apr 12th, 2024
Zoll Says 'Cookie-Cutter' Hack Claims Don't Show Harm

Zoll Medical Corp. is asking a Boston federal judge to toss a proposed class action brought by medical device customers whose personal information was released during a ransomware attack last year...

Business Wire
Apr 2nd, 2024
Zoll Receives Innovative Technology Contract From Vizient For Therox Supersaturated Oxygen (Sso2) Therapy

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it has received an Innovative Technology contract from Vizient, Inc., the nation’s largest provider-driven healthcare performance improvement company. The contract was awarded based on the recommendation of hospital experts who serve on one of Vizient’s customer-led councils, and it signifies unique qualities that potentially bring improvement to patient cardiovascular care. Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient’s Innovative Technology Program. Vizient customer-led councils identify technologies that have the potential to enhance clinical care, patient safety, healthcare worker safety, or improve business operations of healthcare organizations. “Each year, more than 258,000 patients in the U.S. access emergency rooms as a result of heart attacks,1” said Matt Rochner, TherOx General Manager

Business Wire
Feb 13th, 2024
Zoll Jednym Z Pierwszych Producentów Aed Certyfikowanych Zgodnie Z Unijnym Rozporządzeniem W Sprawie Wyrobów Medycznych

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL®, spółka z Grupy Asahi Kasei produkująca wyroby medyczne i powiązane oprogramowanie, ogłosiła dzisiaj, że defibrylator ZOLL AED 3® został zatwierdzony zgodnie z unijnym rozporządzeniem (UE) 2017/745 w sprawie wyrobów medycznych, zwanym w skrócie „EU MDR”. EU MDR to wprowadzone przez Unię Europejską rozporządzenie 2017/745 w sprawie wyrobów medycznych przyjęte przez Parlament Europejski i Radę w 2017 r. Celem EU MDR jest zagwarantowanie wysokich standardów bezpieczeństwa i jakości wyrobów medycznych wytwarzanych w państwach członkowskich Unii Europejskiej lub dostarczanych na ich terytorium. Firma ZOLL uzyskała właśnie oznakowanie CE swojego defibrylatora ZOLL AED 3 zgodnie z przepisami EU MDR

Business Wire
Feb 8th, 2024
Zoll È Tra Le Prime Aziende A Ricevere Lapprovazione Per I Dae Ai Sensi Del Regolamento Ue Sulla Certificazione Per I Dispositivi Medici (Mdr)

CHELMSFORD, Massachusetts--(BUSINESS WIRE)--ZOLL®, una società di Asahi Kasei che produce dispositivi medici e soluzioni software correlate, ha annunciato oggi che il defibrillatore ZOLL AED 3® ha ricevuto l'approvazione ai sensi del regolamento UE 2017/745 relativo ai dispositivi medici, noto comunemente come MDR UE. Il regolamento MDR UE è il regolamento europeo in materia di dispositivi medici 2017/745 proposto nel 2017 dal Parlamento europeo e dal Consiglio dell'Unione europea. Lo scopo del MDR UE è di garantire un elevato standard di sicurezza e qualità per i dispositivi medici prodotti o forniti all'interno dei paesi membri dell'Unione europea. ZOLL ha ottenuto la marcatura CE per il suo defibrillatore ZOLL AED 3 ai sensi del regolamento MDR UE